PTK2 and cancer: Initial studies in squamous cell carcinoma (SCC) on the connection between FAK and the immune system showed that nuclear-targeted FAK promotes tumour immune evasion, due to exhaustion of CD8+ T cells and the recruitment of pro-tumourigenic regulatory T cells (Tregs), driving cancer progression.